Day: August 10, 2022

Form 8.3 – [CareTech Holdings plc – 09 08 2022] – (CGWL)

Written by Customer Service on August 10, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree CARETECH HOLDINGS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

AITX’s Subsidiary Robotic Assistance Devices to Deploy its First School Firearm Detection System

Written by Customer Service on August 10, 2022. Posted in Public Companies.

Artificial Intelligence Technology Solutions, Inc. Illustration of a common security camera with images of AI-powered analytics including firearm detection, human detection, and license plate recognition. RAD has received an order from a private school for 2 firearm detection systems and has announced plans to integrate RADSoC with existing web-connected camera networks.RAD Also Announces RADSoC Integration with Existing Security Camera Networks Detroit, Michigan, Aug. 10, 2022 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc., (OTCPK:AITX), today announced that its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD) has received a Letter of Intent (LOI) with an east coast parochial school to deploy 2 ROSA security robots with firearm detection technology. Coinciding with this deployment, RAD...

VYNE Therapeutics Announces Results from its Phase 2a Trial of FMX114 for the Treatment of Mild-to-Moderate Atopic Dermatitis

Written by Customer Service on August 10, 2022. Posted in Public Companies.

BRIDGEWATER, N.J., Aug. 10, 2022 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced results from the Phase 2a segment of a Phase 1b/2a clinical trial evaluating FMX114 for the treatment of mild-to-moderate atopic dermatitis (“AD”). Study VY2021-01 did not meet its primary endpoint based on the absolute and percent change relative to baseline in the Atopic Dermatitis Severity Index (“ADSI”). The Phase 2a study of FMX114 enrolled 21 patients and was designed to evaluate four weeks of FMX114 treatment in patients with mild-to-moderate AD compared to vehicle control. The enrollment criteria specified that subjects must have two comparable target...

AcuityAds Reports Second Quarter 2022 Financial Results

Written by Customer Service on August 10, 2022. Posted in Earnings Releases And Operating Results.

Generated $28.3 million in Total Revenueillumin Revenue Up 96% YOY to $10.2 million TORONTO and NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) — AcuityAds Holdings Inc. (TSX:AT) (NASDAQ:ATY) (“AcuityAds” or “Company”), a Journey Advertising technology company that empowers marketers to make smarter decisions about communicating with online consumers, today announced its financial results for the three months ended June 30, 2022. Second Quarter 2022 HighlightsTotal revenue for the three months ended June 30, 2022, was $28.3 million, up 18.6% sequentially. On a year over year basis, revenues decreased by 6.6% which was largely anticipated as we continue to build and transition our sales team from our legacy DSP product to our Journey Advertising product, illumin. As previously communicated, we believe our new sales personnel will become...

Pieridae Releases Q2 2022 Results: Record Net Operating Income of $56 million drives $23 million in Debt Principal Repayment

Written by Customer Service on August 10, 2022. Posted in Earnings Releases And Operating Results.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN UNITED STATES CALGARY, Alberta, Aug. 10, 2022 (GLOBE NEWSWIRE) — Pieridae Energy Limited (“Pieridae” or the “Company”) (PEA.TO) announces the release of its second quarter 2022 financial and operating results, highlighted by record net operating income, material deleveraging and minor non-core asset divestitures. HighlightsDuring Q2 2022 Pieridae:Generated record quarterly Net Operating Income1 (“NOI”) of $56.0 million ($0.35 per basic and $0.35 per fully diluted share) up 287% from $14.4 million in the comparable period in 2021; Generated Adjusted Funds Flow from Operations1 (“AFFO”) of $48.7 million ($0.31 per basic and $0.30 per fully diluted share), up 472% from $8.5 million in Q2 2021; Generated net income of $23.0 million ($0.15 per basic and...

NewLake Capital Partners Reports Second Quarter 2022 Financial Results

Written by Customer Service on August 10, 2022. Posted in Earnings Releases And Operating Results.

– Second Quarter 2022 Revenue Totaled $10.5 Million, an Increase of 59% Year-Over-Year – – Second Quarter 2022 Net Income Attributable to Common Stockholders totaled $3.8 Million, FFO totaled $6.5 Million, and AFFO totaled $8.7 Million – – Conference Call and Webcast Scheduled for Today, Wednesday, August 10, 2022, at 10 a.m. Eastern Time – NEW CANAAN, Conn., Aug. 10, 2022 (GLOBE NEWSWIRE) — NewLake Capital Partners, Inc. (OTCQX: NLCP) (the “Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, today announced its financial results for the second quarter ended June 30, 2022. Anthony Coniglio, President and Chief Executive Officer, said, “We continue to be pleased with our AFFO growth, which has allowed us to increase our dividend for the fifth...

REMINDER/KP Tissue to Release its Financial Results and those of Kruger Products L.P. for the Second Quarter of 2022

Written by Customer Service on August 10, 2022. Posted in Public Companies.

MISSISSAUGA, Ontario, Aug. 10, 2022 (GLOBE NEWSWIRE) — KP Tissue Inc. (“KPT”) (TSX:KPT), which holds a limited partnership interest in Kruger Products L.P. (“KPLP”), will release the financial results for KPT and KPLP for the second quarter of 2022 on Thursday, August 11 before the market opens. KPT will hold its conference call the same day at 8:30 a.m. Eastern Time. Details of the Conference Call Via telephone: 1-888-396-8049 or 416-764-8646Via the internet at: www.kptissueinc.com Presentation material referenced during the conference call will be available at www.kptissueinc.com Conference Call Rebroadcast A rebroadcast of the conference call will be available until midnight, August 18, 2022 by dialing 1-877-674-7070 or 416-764-8692 and entering passcode 464389. The replay of the webcast will remain available on the web site...

REMINDER/Supremex Announces Date of Its 2022 Second Quarter Results Conference Call

Written by Customer Service on August 10, 2022. Posted in Public Companies.

MONTREAL, Aug. 10, 2022 (GLOBE NEWSWIRE) — Supremex Inc. (“Supremex” or the “Company”) (TSX: SXP), a leading North American manufacturer and marketer of envelopes and a growing provider of paper-based packaging solutions, will release its results for the Second quarter ended June 30, 2022, before markets open on Thursday, August 11, 2022. A conference call to discuss these results will be held on the same day, at 11:00 a.m. (Eastern Time). Conference Call: A live broadcast of the Conference Call will be available on the Company’s website, in the Investors section under Webcast. To participate (professional investment community only) or to listen to the live conference call, please dial the following numbers. We suggest that participants call-in at least 5 minutes prior to the scheduled start time:• Confirmation number: 66330361• Local...

Verde achieves 782% EBITDA and 362% revenue growths in Q2 2022

Written by Customer Service on August 10, 2022. Posted in Earnings Releases And Operating Results.

(All figures are in Canadian dollars, unless stated otherwise. Average exchange rate in Q2 2022: C$1.00 = R$3.99) BELO HORIZONTE, Brazil, Aug. 10, 2022 (GLOBE NEWSWIRE) — Verde AgriTech Ltd (TSX: “NPK”) (“Verde” or the “Company”) is pleased to announce its financial results for the second quarter of 2022 (“Q2 2022”). Q2 2022 FINANCIALSRevenue increased by 362% in Q2 2022, to $24,861,000 compared to $5,376,000 in Q2 2021. Revenue in Brazilian Real (“R$”) increased by 327% in Q2 2022, to R$99,185,000 compared to R$23,215,000 in Q2 2021. Sales of Verde’s multinutrient potassium products, BAKS® and K Forte® sold internationally as Super Greensand® (the “Product”) by volume increased by 112% in Q2 2022, to 202,255 tonnes, compared to 95,551 tonnes sold in Q2 2021. Gross margin increased to 79% in Q2 2022, compared to 72%...

SAB Biotherapeutics Provides Company Update for Q2 2022 Financial Results

Written by Customer Service on August 10, 2022. Posted in Earnings Releases And Operating Results.

Expects cash is sufficient to fund operations for the forward twelve months SIOUX FALLS, S.D., Aug. 10, 2022 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, today reported financial results for the second quarter ended June 30, 2022 and provided a company update. “We continue to utilize our capabilities and infrastructure to advance our development pipeline in immunotherapeutics directed at unmet medical needs in influenza and Clostridioides difficile (C. diff.) as well as discovery programs in autoimmune disease and oncology. Furthermore, with the validation of our technology in clinical trials in the last year, we are...

Day: August 10, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice